Asset Strategy and Investment /
Branding and Positioning /
Commercial Strategy /
Insight Generation /
Lifecycle Management /
Market Access Strategy /
Market Landscapes /
Patient Journeys /
Pricing /
Value Story Development /
Workshops and Brainstorming /
Case Study: Understanding and assessing opportunity in autoimmune disease
Problem
The early stage products team at a top 5 pharmaceutical company wanted to understand the potential clinical and commercial attractiveness of selected, diverse auto-immune indications
Solution
- Desk research and one-to-one interviews with KOLs and payers to understand and score the clinical and commercial attractiveness of each opportunity using comprehensive criteria.
- Leverage proprietary Multi-Variable Analysis (MVA) engine to build weighted assessments for decision making, which included:
- Burden of disease and level of unmet need in each population
- The underlying disease causes and the scientific rationale / appeal of MoAs that could address these causes
- Technical and regulatory feasibility of clinical development
- Hurdles and required outcomes for new treatments
- Commercial viability (including patient group size and trends, likely future competitive environment and market access issues)
Outcome
- Identification and prioritization of the most attractive opportunities, including clusters of diseases / indications and targets / MoAs that could drive opportunity pathways for the auto-immune portfolio
- Clear direction on the business opportunities and potential development strategies for the auto-immune portfolio